These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7369893)

  • 1. A comparison of the relative efficacy of CAPD and hemodialysis in the control of solute concentration.
    Hiatt MP; Pyle WK; Moncrief JW; Popovich RP
    Artif Organs; 1980 Feb; 4(1):37-43. PubMed ID: 7369893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of CAPD and PD-plus effectiveness.
    Iles-Smith H; Curwell J; Gokal R
    EDTNA ERCA J; 1999; 25(3):27-9. PubMed ID: 10786491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is continuous ambulatory peritoneal dialysis adequate long-term therapy for end-stage renal disease? A critical assessment.
    Diaz-Buxo JA
    J Am Soc Nephrol; 1992 Nov; 3(5):1039-48. PubMed ID: 1482746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urea kinetics evaluation of hemodialysis and CAPD patients.
    Acchiardo SR; Kraus AP; LaHatte G; Kaufman PA; Adkins D; Moore LW
    Adv Perit Dial; 1992; 8():55-8. PubMed ID: 1361852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between urea removal in hemodialysis and continuous ambulatory peritoneal dialysis using a mathematical kinetic model.
    Kanamori T; Sakai K
    Int J Artif Organs; 1997 Mar; 20(3):158-62. PubMed ID: 9151151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics.
    Gerig JS; Bolton ND; Swabb EA; Scheld WM; Bolton WK
    Kidney Int; 1984 Sep; 26(3):308-18. PubMed ID: 6542606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of peritoneal mass transport by three-pore model in children.
    Schaefer F; Haraldsson B; Haas S; Simkova E; Feber J; Mehls O
    Kidney Int; 1998 Oct; 54(4):1372-9. PubMed ID: 9767558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to improve clinical outcomes in peritoneal dialysis patients: delivered dose and membrane transport.
    Churchill DN
    Am J Kidney Dis; 1998 Dec; 32(6 Suppl 4):S58-62. PubMed ID: 9892367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urea kinetic and middle molecule approaches to assessing the adequacy of hemodialysis and CAPD.
    Keshaviah P
    Kidney Int Suppl; 1993 Feb; 40():S28-38. PubMed ID: 8445836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tidal peritoneal dialysis: kinetics and protein balance.
    Flanigan MJ; Lim VS; Pflederer TA
    Am J Kidney Dis; 1993 Nov; 22(5):700-7. PubMed ID: 8238016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transport kinetics of pseudouridine during hemodialysis and continuous ambulatory peritoneal dialysis.
    Struijk DG; Schoots AC; Koole LH; van der Reijden HJ; Koomen GC; Krediet RT; Arisz L
    J Lab Clin Med; 1991 Jul; 118(1):74-80. PubMed ID: 2066647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal urea and creatinine clearances in continuous peritoneal dialysis patients with different types of peritoneal solute transport.
    Tzamaloukas AH; Murata GH; Piraino B; Rao P; Bernardini J; Malhotra D; Oreopoulos DG
    Kidney Int; 1998 May; 53(5):1405-11. PubMed ID: 9573559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous ambulatory peritoneal dialysis (CAPD) in the treatment of end-stage renal failure.
    Thomson NM; Walker RG; Whiteside G; Scott DF; Atkins RC
    Proc Eur Dial Transplant Assoc; 1979; 16():171-7. PubMed ID: 548978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of continuous ambulatory peritoneal dialysis (CAPD) in a program for the treatment of chronic renal insufficiency. Problems posed by transfer of CAPD to transplantation or hemodialysis].
    Canaud B; Mion C
    Nephrologie; 1995; 16(1):129-35. PubMed ID: 7700413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
    Sahin S; Sahin GM; Ergin H; Kantarci G
    Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics.
    Badve SV; Zimmerman DL; Knoll GA; Burns KD; McCormick BB
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1711-7. PubMed ID: 18815242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relevance of urea kinetic modeling to CAPD.
    Lysaght MJ; Pollock CA; Hallet MD; Ibels LS; Farrell PC
    ASAIO Trans; 1989; 35(4):784-90. PubMed ID: 2611047
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of automated peritoneal dialysis on the decrease in residual renal function.
    Hufnagel G; Michel C; Queffeulou G; Skhiri H; Damieri H; Mignon F
    Nephrol Dial Transplant; 1999 May; 14(5):1224-8. PubMed ID: 10344365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of peritoneal dialysis method on residual renal function in children.
    Roszkowska-Blaim M; Skrzypczyk P; Jander A; Tkaczyk M; Bałasz-Chmielewska I; Zurowska A; Drozdz D; Pietrzyk JA
    Adv Perit Dial; 2012; 28():112-9. PubMed ID: 23311226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with hemodialysis and peritoneal dialysis.
    Suzuki H; Hoshi H; Inoue T; Kikuta T; Tsuda M; Takenaka T
    Contrib Nephrol; 2012; 177():71-83. PubMed ID: 22613917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.